Showing results (51-60 of 2,336) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|March 10, 2019
Inoperable Pulmonary Carcinoid Tumors: Local Control Rates With Stereotactic Body Radiotherapy/Hypofractionated RT With Image-Guided RadiotherapyDeepinder Singh, Yuhchyau Chen, Michael A Cummings, et al.Clinical Lung Cancer|November 15, 2018
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung CancerYoung Kwang Chae, Andrew A Davis, Kirtee Raparia, et al.Clinical Lung Cancer|February 28, 2019
Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study ProtocolBenjamin Levy, Luis Paz-Ares, Jaafar Bennouna, et al.Clinical Lung Cancer|February 14, 2021
Treatment at Integrated Centers Might Bridge the Academic-Community Survival Gap in Patients With Metastatic Non-Small Cell Carcinoma of the LungSendhilnathan Ramalingam, Michaela A Dinan, Jeffrey CrawfordClinical Lung Cancer|January 24, 2021
Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung CancerAtsushi Kamigaichi, Yasuhiro Tsutani, Takahiro Mimae, et al.Clinical Lung Cancer|February 22, 2021
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)Masayuki Takeda, Mototsugu Shimokawa, Atsushi Nakamura, et al.Clinical Lung Cancer|February 25, 2017
A Multimedia Self-management Intervention to Prepare Cancer Patients and Family Caregivers for Lung Surgery and Postoperative RecoveryVirginia Sun, Dan J Raz, Nora Ruel, et al.Clinical Lung Cancer|March 22, 2017
Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung CancerKarlijn J G Schulkes, Esteban T D Souwer, Leontine J R van Elden, et al.Clinical Lung Cancer|January 14, 2021
Characteristics and Outcomes of Lung Cancer Screening Among Individuals With or Without Cancer HistoryBradley Maller, Vani N Simmons, Margaret M Byrne, et al.Clinical Lung Cancer|November 24, 2004
Clinical benefit of zoledronic acid in patients with lung cancer and other solid tumors: analysis based on history of skeletal complicationsVera Hirsh, N Simon Tchekmedyian, Lee S Rosen, et al.Pageof 234